The optimal management for low-grade dysplasia (LGD) in Barrett's esophagus is unclear.
In this article the importance of LGD is discussed, including the significant risk of progression …

Background Barrett's esophagus (BE) is the most important identifiable risk factor for the
progression to esophageal adenocarcinoma. Methods This article reviews the current …

Endoscopic therapy of Barrett's esophagus is feasible and likely to decrease the future risk
of development of esophageal adenocarcinoma. The most commonly utilized therapy is …

Barrett's esophagus is a premalignant condition of the esophagus in which the squamous
epithelium of the lower end of the esophagus is replaced with columnar epithelium. Since …

Results: Eleven patients (eight men; median age 60 years) were treated (median Barrett's
length 5 cm). Visible abnormalities were removed with endoscopic resection in six patients …

Barrett's oesophagus is a major risk factor for developing oesophageal adenocarcinoma.
Ablation by argon plasma coagulation (APC) and photodynamic therapy (PDT) is currently …

Methods: Visible abnormalities were removed with endoscopic resection prior to ablation.
Persistence of dysplasia and absence of IMC were confirmed with biopsy after endoscopic …

The incidence of Barrett's esophagus (BE)‐related neoplasia in Western countries has
increased in the past several decades and, even in Eastern countries, it appears to be …

Objective Endoscopic mucosal ablation is a promising technique that is used to treat
dysplastic Barrett's oesophagus. The purpose of this study was to investigate the efficacy …

BACKGROUND & AIMS:: Although esophagectomy is the standard of care for treating early
adenocarcinoma in Barrett's esophagus, the procedure is associated with significant …